• NewAmsterdam Pharma (NASDAQ:NAMS) Issues Earnings Results, Misses Estimates By $0.47 EPS

    Источник: Buzz FX / 27 фев 2025 13:56:19   America/Chicago


    NewAmsterdam Pharma (NASDAQ:NAMS) Issues Earnings Results, Misses Estimates By $0.47 EPS Written by MarketBeat February 27, 2025 Share Link copied to clipboard. NewAmsterdam Pharma ( NASDAQ:NAMS - Get Free Report ) announced its quarterly e
    Read more...
Опубликовать